Surmodics Gross Profit 2010-2025 | SRDX
Surmodics gross profit from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| Surmodics Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $93 |
| 2023 | $108 |
| 2022 | $80 |
| 2021 | $88 |
| 2020 | $80 |
| 2019 | $86 |
| 2018 | $67 |
| 2017 | $62 |
| 2016 | $60 |
| 2015 | $53 |
| 2014 | $49 |
| 2013 | $48 |
| 2012 | $45 |
| 2011 | $46 |
| 2010 | $48 |
| 2009 | $114 |
| Surmodics Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-03-31 | $20 |
| 2024-12-31 | $22 |
| 2024-09-30 | $25 |
| 2024-06-30 | $22 |
| 2024-03-31 | $25 |
| 2023-12-31 | $22 |
| 2023-09-30 | $21 |
| 2023-06-30 | $46 |
| 2023-03-31 | $21 |
| 2022-12-31 | $20 |
| 2022-09-30 | $20 |
| 2022-06-30 | $20 |
| 2022-03-31 | $21 |
| 2021-12-31 | $19 |
| 2021-09-30 | $20 |
| 2021-06-30 | $19 |
| 2021-03-31 | $31 |
| 2020-12-31 | $19 |
| 2020-09-30 | $19 |
| 2020-06-30 | $22 |
| 2020-03-31 | $19 |
| 2019-12-31 | $19 |
| 2019-09-30 | $27 |
| 2019-06-30 | $21 |
| 2019-03-31 | $20 |
| 2018-12-31 | $19 |
| 2018-09-30 | $19 |
| 2018-06-30 | $18 |
| 2018-03-31 | $16 |
| 2017-12-31 | $14 |
| 2017-09-30 | $17 |
| 2017-06-30 | $15 |
| 2017-03-31 | $15 |
| 2016-12-31 | $15 |
| 2016-09-30 | $15 |
| 2016-06-30 | $17 |
| 2016-03-31 | $14 |
| 2015-12-31 | $14 |
| 2015-09-30 | $15 |
| 2015-06-30 | $14 |
| 2015-03-31 | $12 |
| 2014-12-31 | $12 |
| 2014-09-30 | $13 |
| 2014-06-30 | $13 |
| 2014-03-31 | $12 |
| 2013-12-31 | $12 |
| 2013-09-30 | $12 |
| 2013-06-30 | $12 |
| 2013-03-31 | $12 |
| 2012-12-31 | $12 |
| 2012-09-30 | $12 |
| 2012-06-30 | $12 |
| 2012-03-31 | $11 |
| 2011-12-31 | $10 |
| 2011-09-30 | $12 |
| 2011-06-30 | $12 |
| 2011-03-31 | $11 |
| 2010-12-31 | $11 |
| 2010-09-30 | $13 |
| 2010-06-30 | $16 |
| 2010-03-31 | $16 |
| 2009-12-31 | $15 |
| 2009-09-30 | $17 |
| 2009-06-30 | $16 |
| 2009-03-31 | $19 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.422B | $0.126B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.634B | 27.97 |
| Boston Scientific (BSX) | United States | $152.531B | 38.19 |
| Stryker (SYK) | United States | $145.427B | 30.41 |
| EssilorLuxottica (ESLOY) | France | $127.535B | 0.00 |
| Medtronic (MDT) | Ireland | $109.709B | 15.55 |
| Haleon (HLN) | United Kingdom | $49.754B | 28.33 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.468B | 0.00 |
| ResMed (RMD) | United States | $36.224B | 27.21 |
| GE HealthCare Technologies (GEHC) | United States | $32.583B | 15.47 |
| Agilent Technologies (A) | United States | $32.148B | 20.88 |
| Terumo (TRUMY) | Japan | $26.857B | 34.88 |
| Insulet (PODD) | United States | $22.748B | 89.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.431B | 15.40 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.172B | 11.67 |
| Baxter (BAX) | United States | $15.441B | 11.53 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.754B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.002B | 20.89 |
| Lantheus Holdings (LNTH) | United States | $5.375B | 13.56 |
| Prestige Consumer Healthcare (PBH) | United States | $4.194B | 18.74 |
| Perrigo (PRGO) | Ireland | $3.646B | 9.24 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.346B | 15.24 |
| ICU Medical (ICUI) | United States | $3.213B | 23.69 |
| Envista Holdings (NVST) | United States | $3.174B | 26.38 |
| GN Store Nord (GNNDY) | Denmark | $2.155B | 17.85 |
| QuidelOrtho (QDEL) | United States | $2.048B | 14.09 |
| LeMaitre Vascular (LMAT) | United States | $1.872B | 41.85 |
| AtriCure (ATRC) | United States | $1.719B | 0.00 |
| Neogen (NEOG) | United States | $1.302B | 16.67 |
| Acuren (TIC) | United States | $1.300B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.196B | 12.14 |
| Green Thumb Industries (GTBIF) | United States | $1.110B | 24.97 |
| BioLife Solutions (BLFS) | United States | $1.016B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.986B | 12.60 |
| InMode (INMD) | Israel | $0.930B | 9.37 |
| Evolus (EOLS) | United States | $0.642B | 0.00 |
| CeriBell (CBLL) | United States | $0.612B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.544B | 0.00 |
| Valneva SE (VALN) | France | $0.519B | 0.00 |
| Owens & Minor (OMI) | United States | $0.517B | 4.29 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.326B | 11.98 |
| Aurora Cannabis (ACB) | Canada | $0.302B | 53.70 |
| Cresco Labs (CRLBF) | United States | $0.277B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.268B | 22.63 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.75 |
| Sanuwave Health (SNWV) | United States | $0.242B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.46 |
| Brainsway (BWAY) | Israel | $0.192B | 50.95 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Omeros (OMER) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.81 |
| Organigram Global (OGI) | Canada | $0.178B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 16.58 |
| Jin Medical (ZJYL) | China | $0.122B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.62 |
| Agape ATP (ATPC) | $0.081B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| Apyx Medical (APYX) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Nephros (NEPH) | United States | $0.035B | 46.71 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |